May 3, 2021 Share
Russia is turning to multiple Chinese firms to manufacture the Sputnik V coronavirus vaccine in an effort to speed up production as demand soars for its shot.
Russia has announced three deals totaling 260 million doses with Chinese vaccine companies in recent weeks. It’s a decision that could mean quicker access to a shot for countries in Latin America, the Middle East, and Africa that have ordered Russia’s vaccine, as the U.S. and the European Union focus mainly on domestic vaccination needs.
Earlier criticism about Russia’s vaccine have been largely quieted by data published in the British medical journal The Lancet that said large-scale testing showed it to be safe, with an efficacy rate of 91%.
Advertisement
Russia is turning to multiple Chinese firms to manufacture the Sputnik V coronavirus vaccine in an effort to speed up production as demand soars for its shot.
Russia has announced three deals totaling 260 million doses with Chinese vaccine companies in recent weeks. It’s a decision that could mean quicker access to a shot for countries in Latin America, the Middle East, and Africa that have ordered Russia’s vaccine, as the U.S. and the European Union focus mainly on domestic vaccination needs.
Earlier criticism about Russia’s vaccine have been largely quieted by data published in the British medical journal The Lancet that said large-scale testing showed it to be safe, with an efficacy rate of 91 percent.
Russia has announced three deals totaling 260 million doses with Chinese vaccine companies in recent weeks. It s a decision that could mean quicker access to a shot for countries in Latin America, the Middle East, and Africa that have ordered Russia s vaccine, as the US and the European Union focus mainly on domestic vaccination needs. Earlier criticism about Russia s vaccine have been largely quieted by data published in the British medical journal The Lancet that said large-scale testing showed it to be safe, with an efficacy rate of 91 per cent. Yet, experts have questioned whether Russia can fulfill its pledge to countries across the world. While pledging hundreds of millions of doses, it has only delivered a fraction.
Russia turns to China to make Sputnik shots to meet demand
Business Related
Better
FILE - In this Dec. 10, 2020, file photo, a Russian medical worker prepares a shot of Russia s Sputnik V coronavirus vaccine in Moscow. Russia is turning to multiple Chinese firms to manufacture the Sputnik V coronavirus vaccine in an effort to speed up production as demand soars for its shot. (AP Photo/Pavel Golovkin, File)
TAIPEI, Taiwan – Russia is turning to multiple Chinese firms to manufacture the Sputnik V coronavirus vaccine in an effort to speed up production as demand soars for its shot.
Russia has announced three deals totalling 260 million doses with Chinese vaccine companies in recent weeks. It’s a decision that could mean quicker access to a shot for countries in Latin America, the Middle East, and Africa that have ordered Russia’s vaccine, as the U.S. and the European Union focus mainly on domestic vaccination needs.
ABC News
Turn on desktop notifications for breaking stories about interest?
OffOn
Russia, facing lags, turns to China to produce Sputnik shots
Russia is turning to multiple Chinese firms to manufacture the Sputnik V coronavirus vaccine in an effort to speed up production as demand soars
By HUIZHONG WU and DARIA LITVINOVA Associated Press
May 3, 2021, 4:37 AM
• 5 min read
The Associated Press
FILE - In this Dec. 10, 2020, file photo, a Russian medical worker prepares a shot of Russia s Sputnik V coronavirus vaccine in Moscow. Russia is turning to multiple Chinese firms to manufacture the Sputnik V coronavirus vaccine in an effort to speed up production as demand soars for its shot. (AP Photo/Pavel Golovkin, File)